Loading…

Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom

Introduction New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benef...

Full description

Saved in:
Bibliographic Details
Published in:Hemodialysis international 2022-07, Vol.26 (3), p.287-294
Main Authors: Ferguson, Thomas W., Harper, Gerard D., Milad, John E., Komenda, Paul V. J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063
cites cdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063
container_end_page 294
container_issue 3
container_start_page 287
container_title Hemodialysis international
container_volume 26
creator Ferguson, Thomas W.
Harper, Gerard D.
Milad, John E.
Komenda, Paul V. J.
description Introduction New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home. Methods We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature. Findings Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center. Discussion We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities.
doi_str_mv 10.1111/hdi.12994
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2618502305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618502305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</originalsourceid><addsrcrecordid>eNp1kEtOwzAQhi0EolBYcAHkJQiltR3bSZYoPFpRCSTo2nIcmxrl0caJUHYcgTNyEkxT2DHSaGbxzafRD8AZRhPsa7rK7QSTJKF74AgzSgIasXjf7zQhQcRCNgLHzr0hRDBC_BCMQoYQ9n0EntLatbA2sF1puOlk1Ur4nF7BlS7r3Mqid9ZB17tWl9DUDXS6MF8fn0o2Gtpqe7WsbKtz-GCr17wuT8CBkYXTp7s5Bsu725d0Fiwe7-fp9SJQJGI0wKHKeM55FkrGMWYxJUaayP-tMmyQVLnSmmYmCQnxXKQ5VQoxHEdxlDHEwzG4GLzrpt502rWitE7popCVrjsnCMcxQyREzKOXA6qa2rlGG7FubCmbXmAkfgIUPkCxDdCz5zttl5U6_yN_E_PAdADebaH7_01idjMflN8brXmX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618502305</pqid></control><display><type>article</type><title>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Ferguson, Thomas W. ; Harper, Gerard D. ; Milad, John E. ; Komenda, Paul V. J.</creator><creatorcontrib>Ferguson, Thomas W. ; Harper, Gerard D. ; Milad, John E. ; Komenda, Paul V. J.</creatorcontrib><description>Introduction New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home. Methods We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature. Findings Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center. Discussion We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities.</description><identifier>ISSN: 1492-7535</identifier><identifier>ISSN: 1542-4758</identifier><identifier>EISSN: 1542-4758</identifier><identifier>DOI: 10.1111/hdi.12994</identifier><identifier>PMID: 35001500</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>cost effectiveness ; Cost-Benefit Analysis ; dialysis ; economic analysis ; hemodialysis ; Hemodialysis, Home ; Humans ; Kidney Failure, Chronic - therapy ; Peritoneal Dialysis ; Renal Dialysis ; Self Care</subject><ispartof>Hemodialysis international, 2022-07, Vol.26 (3), p.287-294</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of International Society for Hemodialysis.</rights><rights>2022 The Authors. Hemodialysis International published by Wiley Periodicals LLC on behalf of International Society for Hemodialysis.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</citedby><cites>FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35001500$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ferguson, Thomas W.</creatorcontrib><creatorcontrib>Harper, Gerard D.</creatorcontrib><creatorcontrib>Milad, John E.</creatorcontrib><creatorcontrib>Komenda, Paul V. J.</creatorcontrib><title>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</title><title>Hemodialysis international</title><addtitle>Hemodial Int</addtitle><description>Introduction New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home. Methods We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature. Findings Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center. Discussion We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities.</description><subject>cost effectiveness</subject><subject>Cost-Benefit Analysis</subject><subject>dialysis</subject><subject>economic analysis</subject><subject>hemodialysis</subject><subject>Hemodialysis, Home</subject><subject>Humans</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Peritoneal Dialysis</subject><subject>Renal Dialysis</subject><subject>Self Care</subject><issn>1492-7535</issn><issn>1542-4758</issn><issn>1542-4758</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kEtOwzAQhi0EolBYcAHkJQiltR3bSZYoPFpRCSTo2nIcmxrl0caJUHYcgTNyEkxT2DHSaGbxzafRD8AZRhPsa7rK7QSTJKF74AgzSgIasXjf7zQhQcRCNgLHzr0hRDBC_BCMQoYQ9n0EntLatbA2sF1puOlk1Ur4nF7BlS7r3Mqid9ZB17tWl9DUDXS6MF8fn0o2Gtpqe7WsbKtz-GCr17wuT8CBkYXTp7s5Bsu725d0Fiwe7-fp9SJQJGI0wKHKeM55FkrGMWYxJUaayP-tMmyQVLnSmmYmCQnxXKQ5VQoxHEdxlDHEwzG4GLzrpt502rWitE7popCVrjsnCMcxQyREzKOXA6qa2rlGG7FubCmbXmAkfgIUPkCxDdCz5zttl5U6_yN_E_PAdADebaH7_01idjMflN8brXmX</recordid><startdate>202207</startdate><enddate>202207</enddate><creator>Ferguson, Thomas W.</creator><creator>Harper, Gerard D.</creator><creator>Milad, John E.</creator><creator>Komenda, Paul V. J.</creator><general>John Wiley &amp; Sons, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202207</creationdate><title>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</title><author>Ferguson, Thomas W. ; Harper, Gerard D. ; Milad, John E. ; Komenda, Paul V. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>cost effectiveness</topic><topic>Cost-Benefit Analysis</topic><topic>dialysis</topic><topic>economic analysis</topic><topic>hemodialysis</topic><topic>Hemodialysis, Home</topic><topic>Humans</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Peritoneal Dialysis</topic><topic>Renal Dialysis</topic><topic>Self Care</topic><toplevel>online_resources</toplevel><creatorcontrib>Ferguson, Thomas W.</creatorcontrib><creatorcontrib>Harper, Gerard D.</creatorcontrib><creatorcontrib>Milad, John E.</creatorcontrib><creatorcontrib>Komenda, Paul V. J.</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hemodialysis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferguson, Thomas W.</au><au>Harper, Gerard D.</au><au>Milad, John E.</au><au>Komenda, Paul V. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom</atitle><jtitle>Hemodialysis international</jtitle><addtitle>Hemodial Int</addtitle><date>2022-07</date><risdate>2022</risdate><volume>26</volume><issue>3</issue><spage>287</spage><epage>294</epage><pages>287-294</pages><issn>1492-7535</issn><issn>1542-4758</issn><eissn>1542-4758</eissn><abstract>Introduction New personal hemodialysis systems, such as the quanta SC+, are being developed; these systems are smaller and simpler to use while providing the clearances of conventional systems. Increasing the uptake of lower‐intensity assistance and full self‐care dialysis may provide economic benefits to the public health payer. In the United Kingdom, most hemodialysis patients currently receive facility‐based dialysis costing more than £36,350 per year including patient transport. As such, we aimed to describe the annual costs of using the SC+ hemodialysis system in the United Kingdom for 3×‐weekly and 3.5×‐weekly dialysis regimens, for self‐care hemodialysis provided both in‐center and at home. Methods We applied a cost minimization approach. Costs for human resources, equipment, and consumables were sourced from the dialysis machine developer (Quanta Dialysis Technologies) based upon discussions with dialysis providers. Facility overhead expenses and transport costs were taken from a review of the literature. Findings Annual costs associated with the use of the SC+ hemodialysis system were estimated to be £26,642 for hemodialysis provided 3× weekly as home self‐care; £30,235 for hemodialysis provided 3× weekly as self‐care in‐center; £29,866 for hemodialysis provided 3.5× weekly as home self‐care; and £36,185 for hemodialysis provided 3.5× weekly as self‐care in‐center. Discussion We found that the SC+ hemodialysis system offers improved cost‐effectiveness for both 3×‐weekly and 3.5×‐weekly self‐care dialysis performed at home or as self‐care in‐center versus fully assisted dialysis provided 3× weekly with conventional machines in facilities.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>35001500</pmid><doi>10.1111/hdi.12994</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1492-7535
ispartof Hemodialysis international, 2022-07, Vol.26 (3), p.287-294
issn 1492-7535
1542-4758
1542-4758
language eng
recordid cdi_proquest_miscellaneous_2618502305
source Wiley-Blackwell Read & Publish Collection
subjects cost effectiveness
Cost-Benefit Analysis
dialysis
economic analysis
hemodialysis
Hemodialysis, Home
Humans
Kidney Failure, Chronic - therapy
Peritoneal Dialysis
Renal Dialysis
Self Care
title Cost of the quanta SC+ hemodialysis system for self‐care in the United Kingdom
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T01%3A05%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cost%20of%20the%20quanta%20SC+%20hemodialysis%20system%20for%20self%E2%80%90care%20in%20the%20United%20Kingdom&rft.jtitle=Hemodialysis%20international&rft.au=Ferguson,%20Thomas%20W.&rft.date=2022-07&rft.volume=26&rft.issue=3&rft.spage=287&rft.epage=294&rft.pages=287-294&rft.issn=1492-7535&rft.eissn=1542-4758&rft_id=info:doi/10.1111/hdi.12994&rft_dat=%3Cproquest_cross%3E2618502305%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2754-13cb6d66b3a56115842faf7758cb1f0acdcee4bf93226d67e64cc0518787b5063%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2618502305&rft_id=info:pmid/35001500&rfr_iscdi=true